- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Guerbet (GRBT)
Guerbet stock price live, this page displays EPA GRBT stock exchange data. View the GRBT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Guerbet real time stock price chart below.
What Is the Guerbet Stock Price Today?
The Guerbet stock price today is 9.68.
What Is the Stock Symbol for Guerbet?
The stock symbol for Guerbet is "GRBT."
What Stock Exchange Does Guerbet Trade On?
Guerbet is listed and trades on the Paris stock exchange.
Is Guerbet a Good Stock to Buy?
Determining whether Guerbet—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRBT quote. (ISIN: FR0000032526)
What Is the Guerbet Stock Price Today?
The Guerbet stock price today is 9.68.
What Is the Stock Symbol for Guerbet?
The stock symbol for Guerbet is "GRBT."
What Stock Exchange Does Guerbet Trade On?
Guerbet is listed and trades on the Paris stock exchange.
Is Guerbet a Good Stock to Buy?
Determining whether Guerbet—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRBT quote. (ISIN: FR0000032526)
Currency in EUR
9.68
+0.02(+0.21%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.37
9.70
52 wk Range
8.01
23.70
Earnings results expected in 6 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.379.70
52 wk Range
8.0123.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GRBT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
11.68
Upside
+20.61%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Guerbet stock falls after H1 profit margin erosion
- Investing.com
- Guerbet stock falls after H1 profit margin erosion
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced MRI examinations; Elucirem, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced resonance imaging; UNIK, a diagnostic imaging interconnected solution; and Artirem, a gadoteric acid. The company also provides OptiStar Elite, a dual head contrast delivery system with an ultrasonic motor; Ready-Box, a contrast media warmer; MRI accessories and consumables for diagnostic imaging; OptiProtect 3S, a suite of services and support solution; Conray/Cysto-Conray, an iothalamate meglumine injection contrast agent for CT; Micropaque/Microtrast, a barium sulfate contrast agent for CT; Optiray, an ioversol contrast agent for CT and Cath lab; Telebrix Gastro, a meglumine ioxitalamate contrast agent for CT; and Xenetix/ScanBag by Xenetix, an Iobitridol contrast agent for CT and Cath lab. In addition, it offers OptiBolus, which allows for a uniform vascular enhancement throughout the procedure; OptiOne, a single head injector; OptiVantage Multi-use, an optimal power injector for X-ray procedures; OptiVantage, a dual-head CT contrast delivery injector; Illumena Néo, a multi-mode contrast delivery injector; Lipiodol Ultra Fluid, an iodinated ethyl ester of fatty acids of poppy seed oil; Qitexio, a range of lipiodol resistant medical devices consisting of medical syringes and a stopcock; Lipiodol Ultra Fluid for use in interventional radiology and women’s health; and Patent Blue V, a pharmaceutical drug for breast cancer. The company was founded in 1901 and is headquartered in Villepinte, France.
Compare GRBT to Peers and Sector
Metrics to compare | GRBT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGRBTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | 22.1x | −0.5x | |
PEG Ratio | 0.00 | −0.08 | 0.00 | |
Price/Book | 0.5x | 2.2x | 2.6x | |
Price / LTM Sales | 0.2x | 2.8x | 3.2x | |
Upside (Analyst Target) | 23.7% | 33.1% | 45.6% | |
Fair Value Upside | Unlock | 13.7% | 5.3% | Unlock |
Analyst Ratings
0 Buy
2 Hold
2 Sell
Ratings:
4 analysts
Overall Consensus
Sell
Analysts 12-Month Price Target:
Average 11.68
(+20.61% Upside)
Earnings
Latest Release
Mar 11, 2026
EPS / Forecast
-8.75 / --
Revenue / Forecast
200M / 220.6M
People Also Watch
FAQ
What Is the Guerbet (GRBT) Stock Price Today?
The Guerbet stock price today is 9.68 EUR.
What Stock Exchange Does Guerbet Trade On?
Guerbet is listed and trades on the Paris Stock Exchange.
What Is the Stock Symbol for Guerbet?
The stock symbol for Guerbet is "GRBT."
What Is the Guerbet Market Cap?
As of today, Guerbet market cap is 122.37M EUR.
What Is Guerbet's Earnings Per Share (TTM)?
The Guerbet EPS (TTM) is -8.59.
When Is the Next Guerbet Earnings Date?
Guerbet will release its next earnings report on Apr 23, 2026.
From a Technical Analysis Perspective, Is GRBT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Guerbet Stock Split?
Guerbet has split 5 times.
How Many Employees Does Guerbet Have?
Guerbet has 2700 employees.
What is the current trading status of Guerbet (GRBT)?
As of Apr 17, 2026, Guerbet (GRBT) is trading at a price of 9.68 EUR, with a previous close of 9.66 EUR. The stock has fluctuated within a day range of 9.37 EUR to 9.70 EUR, while its 52-week range spans from 8.01 EUR to 23.70 EUR.
What Is Guerbet (GRBT) Price Target According to Analysts?
The average 12-month price target for Guerbet is 11.68 EUR, with a high estimate of 13.8 EUR and a low estimate of 9 EUR. 0 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Sell. The stock has an +20.61% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.